πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6159994

Histamine H.sub.3 receptor ligands

The James Black Foundation Limited Β· Granted Tue Dec 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6159712

Methods for enhancing the production of interferon in cell culture

The Regents of the University of California Β· Granted Tue Dec 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6159684

HIV trans-activator TAT binding to CDK7 and activation of CTD phosphorylation

The Regents of the University of California Β· Granted Tue Dec 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6159936

Compositions and methods for treating and preventing microbial and viral infections

The Regents of the University of California Β· Granted Tue Dec 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6156541

Compositions and methods for catalyzing hydrolysis of HIV gp120

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6156321

Tissue factor methods and compositions for coagulation and tumor treatment

The Board of Regents of the University of Texas System Β· Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6155266

Method for treatment of cancer and infectious disease

Maxim Pharmaceuticals, Inc. Β· Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6156788

Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma Β· Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6156773

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6156750

Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised t

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma Β· Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6156723

Compositions comprising inhibitors of estrogen response

The Regents of the University of California Β· Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6153200

Vaccine compositions and methods useful in inducing immune protection against arthritogeni

The Regents of the University of California Β· Granted Tue Nov 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6153421

Cloned genomes of infectious hepatitis C viruses and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6153430

Nucleic acid encoding mesothelin, a differentiation antigen present on mesothelium, mesoth

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6150508

Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane

Northwest Biotherapeutics, Inc. Β· Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6150581

Chitosan/alginate anti-adhesion barrier

United States Surgical Corporation Β· Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6150413

Triaromatic compounds and pharmaceutical/cosmetic compositions comprised thereof

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma Β· Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6150383

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6150164

Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6149931

Methods and pharmaceutical compositions for the closure of retinal breaks

The Regents of the University of California Β· Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6150384

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6147060

Treatment of carcinomas using squalamine in combination with other anti-cancer agents

Magainin Pharmaceuticals Inc. Β· Granted Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6147051

Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofu

Takeda Chemical Industries Ltd. Β· Granted Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6146653

Pharmaceutical preparation and a method for the treatment of diabetes

Diataranz Limited Β· Granted Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired